Cutaneous Lupus Erythematosus and Elidel

• Status: Withdrawn
• Trial end date: 1969-12-31

Summary

This trial evaluates the therapeutic effect of Elidel (pimecrolimus) in comparison to the corresponding vehicle in patients with chronic discoid lupus erythematosus (dLE) or subacute cutaneous lupus erythematosus (scLE).

• Phase: N/A

Details

• Lead Sponsor: University of Leipzig
• Collaborator: Novartis
• Treatments: Pimecrolimus; Tacrolimus